Design of the APPEAR-C3G study: a study to learn how well iptacopan works in people with complement 3 glomerulopathy

Bomback, A. (2023). Plain language summary of the design of the APPEAR-C3G Study: A Study to Learn How Well Iptacopan Works in People with Complement 3 Glomerulopathy. Future Rare Diseases, 3(2). https://doi.org/10.2217/frd-2022-0020
Authors:
Andrew S. Bomback
Affiliated Authors:
Andrew S. Bomback
Columbia Affiliation:
Subjects:
Pathophysiology of Glomerular Diseases and Nephrotic Syndromes (OpenAlex Topic)
Chronic Kidney Disease and Dialysis Treatment (OpenAlex Topic)
Chronic Kidney Disease and its Implications (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.2217/frd-2022-0020
DOI:
10.2217/frd-2022-0020
Journal:
Future Rare Diseases
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: